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Abstract: Toscana virus (TOSV) is a Phlebovirus transmitted by phlebotomine sand flies and is an
important etiological agent of summer meningitis in the Mediterranean basin. Since TOSV infection
is often asymptomatic, we evaluated the seroprevalence in blood donors (BDs) in the Bologna and
Ferrara provinces (Northeastern Italy)—the areas with the highest and lowest numbers of TOSV
neuroinvasive cases in the region, respectively. A total of 1208 serum samples from BDs were collected
in April–June 2014 and evaluated for the presence of specific TOSV-IgG by ELISA. The IgG-reactive
samples were confirmed by indirect immunofluorescence assay (IIF) and by microneutralization
test (MN). Serum samples were defined as positive for anti-TOSV IgG when reactive by ELISA and
by at least one second-level test; TOSV seroprevalence was 6.8% in the Bologna province, while no
circulation of TOSV was detected in the Ferrara province. Sand fly abundance in 2014 was also
estimated by a geographic information system using a generalized linear model applied to a series of
explanatory variables. TOSV seroprevalence rate was strongly associated with the sand fly abundance
index in each municipality, pointing out the strong association between sand fly abundance and
human exposure to TOSV.
Keywords: Toscana virus; viral meningitis; seroprevalence; arbovirus; sand fly; Phlebotomus
spp.; neutralization
1. Introduction
Toscana virus (TOSV) is an arthropod-borne virus belonging to the Phlebovirus genus of the
Phenuiviridae family; this virus is transmitted by phlebotomine sand flies, mainly Phlebotomus perfiliewi,
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Ph. perniciosus, and Ph. tobbi in Europe [1–3]. TOSV was firstly isolated from Ph. perniciosus in Central
Italy (Tuscany) in 1971 [4]; fifteen years later, TOSV infection was reported from returning travelers
who had visited areas where the virus was initially described [5,6].
In the Mediterranean area, phleboviruses transmitted by sand flies belong to one of the following
groups: (i) two International Committee on Taxonomy of Viruses (ICTV) recognized species, i.e.,
sandfly fever Naples (including TOSV and Naples virus) and Salehabad (including Salehabad and
Arbia viruses) and (ii) two tentative species, i.e., sandfly fever Sicilian virus and Corfou virus [7].
Besides TOSV, the sandfly fever Sicilian (SFSV) and sandfly fever Naples (SFNV) viruses exhibit the
widest geographical distribution within the Mediterranean region, which is likely related to the wide
distribution of their proven vector (Ph. papatasi) in this area [4,8–10].
SFSV and SFNV are the etiologic agents of the “pappataci fever” characterized by fever, myalgia,
and headache [11], while TOSV displays a strong neurotropism, being responsible for aseptic meningitis
and meningoencephalitis, mainly associated with a favorable outcome [5,12]. Other phleboviruses
have been related to human pathology; a novel phlebovirus that appeared genetically close to SFSV
was detected during an outbreak of febrile syndrome among Greek soldiers stationed in Cyprus in 2002.
From the location comes the provisional denomination of sandfly fever Cyprus virus (SFCV) [13,14].
In the past two decades, TOSV circulation has been increasingly reported in the Mediterranean
basin; cases of neuroinvasive infection have been observed in residents of or travelers to Portugal,
Spain, Italy, France, Cyprus, Turkey, and Greece [5,11]. Currently, TOSV is a prominent cause of
summer meningitis and encephalitis in Mediterranean Europe [15].
In Italy, TOSV has been detected in several regions including Tuscany, Piedmont, Marche, Umbria,
Lazio, Campania, and Sardinia [4]. Since 1999, autochthonous human cases of TOSV meningitis
have been reported in the Emilia-Romagna region (Northeastern Italy), indicating local circulation
of the virus [16]. In 2010, a surveillance plan to monitor human arboviral cases was adopted by the
Emilia-Romagna region, leading to the detection of 61 cases of TOSV meningitis or meningoencephalitis
in 2010–2012 [17] and 82 cases in summer–autumn 2013 [18]. Two sand fly species are present in the
Emilia-Romagna region, i.e., Ph. perfiliewi and Ph. perniciosus, with an overwhelming presence of the
first species [17].
Since TOSV infection is often asymptomatic [19], we hypothesized that the expected seroprevalence
would be higher in areas with a higher number of TOSV cases. To verify this hypothesis, we performed
a serosurvey for the identification of anti-TOSV antibodies among blood donors (BDs) in the
Emilia-Romagna region. The study was carried out in April–July 2014, involving the central-eastern part
of the region; sera were collected from BDs in areas with the highest and lowest number of neuroinvasive
cases in previous years, i.e., the provinces of Bologna and Ferrara, respectively [17]. Serum samples
were firstly evaluated for the presence of specific IgG by ELISA and only reactive samples were
further tested by indirect immunofluorescence assay (IIF) and by microneutralization assay (MN).
As a secondary aim, we explored the association between the observed TOSV seroprevalence and the
estimated sand fly abundance in the study area.
2. Materials and Methods
2.1. Study Area and Sampling
We conducted a retrospective serological study in healthy Italian individuals volunteering
for blood donation. In Italy, blood donation strictly follows laws and regulations from the Italian
National Transfusion Network [20]. Blood samples were obtained from the Regional Blood Centre
of Emilia-Romagna, Maggiore Hospital of Bologna (Italy), stored at 4 ◦C and sent to the Unit of
Microbiology (St. Orsola-Malpighi University Hospital, Bologna, Italy) within 5 days of collection.
Blood samples were centrifuged and stored at −80 ◦C. The study included BDs residing in the Bologna
and Ferrara provinces, within the Emilia-Romagna region (4,446,220 inhabitants), Italy. From April
to July 2014, 1008 serum samples from BDs residing in Bologna and 200 serum samples from BDs
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residing in Ferrara, respectively, were collected. The number of samples collected was related to the
population’s density; Bologna province has around 1,000,000 inhabitants and Ferrara province around
300,000 inhabitants. The study was performed in accordance with the Declaration of Helsinki. Generic
written informed consent for storage and future use for research purpose was obtained from each
BD before sampling. Blood samples were coded and retrospectively analyzed by serological tests.
As samples were anonymized, no further consent to participate to this study could be requested from
blood donors, according to the Italian Data Protection Authority (Authorization n. 9/2016). All sera
were stored at −80 ◦C until tests were performed.
2.2. Serological Tests for the Detection of Anti-TOSV IgG
Blood samples obtained from BD residing in Bologna (N = 1008) and Ferrara (N = 200) were firstly
analyzed for the presence of antibody to TOSV by an immunoenzymatic assay and only positive sera
were further tested by IIF and MN (Figure 1).
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Figure 1. Work-flow of TOSV serosurvey. Blood donor (BD) sera were collected from the Bologna
and Ferrara provinces (Northeastern Italy) and tested by ELISA for the presence of anti-TOSV IgG.
Samples testing reactive by ELISA were confirmed by indirect immunofluorescence assay (IIF) and
microneutralization test (MN).
2.2.1. Detection of Anti-TOSV IgG by ELISA
Each serum sample was first evaluated for the presence of specific TOSV-IgG using an in-house
ELISA, as described [18]. Briefly, the viral antigen consisted of purified and inactivated virus, obtained
from TOSV strain MRS2010-4319501 isolated in Marseille. The optical density (OD) values were
normalized, and the ratio between normalized OD and the cut-off value was calculated. Samples
presenting a ratio between normalized OD and a cut-off value higher than 1.1 were considered positive,
while samples with a ratio between normalized OD and a cut-off value between 1.0 and 1.1 were
considered borderline.
2.2.2. IIF for Anti-TOSV IgG Detection
All positives and borderline ELISA samples were diluted 1:100 and tested with IIF for the detection
of anti-TOSV IgG (Sandfly fever virus Mosaic 1, Euroimmun, Lubeck, Germany). IIF was performed
following the manufacturer’s instructions. The assay simultaneously detects specific IgG against TOSV,
SFNV, SFSV, and SFCV.
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2.2.3. Detection of Anti-TOSV and Anti-SFSV Neutralizing Antibody
MN was performed as described [18]. Briefly, 100 TCID50 (50% tissue culture
infective dose) of TOSV (strain MRS2010-4319501) or SFSV (strain UVE/SFSV/1943/IT/Sabin,
Ref#001v-EVA77 accessible at https://www.european-virus-archive.com/virus/sandfly-fever-sicilian-
virus-strain-uvesfsv1943itsabin) were added to wells of a 96-well plate containing patient serum and
incubated at 37 ◦C for 1 h. Subsequently, a 100 µL suspension of Vero cells containing approximately
2 × 105 cells/mL was added to each well and incubated for 5 days. The microplates were then read
under an inverted microscope, and the presence (neutralization titer at 10, 20, 40, 80 and 160) or absence
(no neutralization) of cytopathic effect was noted.
2.3. Correlation between Sand Fly Abundance and TOSV Seroprevalence
2.3.1. Estimation of Sand Fly Abundance
Sampling data obtained in the frame of the Emilia-Romagna regional surveillance plan for
West Nile virus and leishmaniasis in 2014 were retrieved for modeling the abundance of sand flies.
Data referred to the Bologna and Ferrara provinces; to improve the model also data from the neighboring
Ravenna province were used. Data concerning 1720 sand flies, sampled between 3 July and 21 August
2014, were used; insects were collected in 29 out of the 62 monitored sites using attractive traps
baited with carbon-dioxide overnight. The summary of entomological data utilized for the model
implementation is reported in Table 1. A generalized linear model (GLM) applied to a series of remote
sensing variables (vegetation index, bioclimatic indexes, land cover, elevation) was used to estimate
the abundance of sand flies (sum of sand flies per site), which was the dependent variable in a Poisson
regression. The first four variables ranked by the model were all linked to the temperature (the
mean diurnal range, the isothermality, temperature seasonality, and the annual temperature range).
The abundance model was carried out in R version 3.3.2 (R Development Core Team 2005) using the
lme4, lattice, Tweedie, boot, raster, sp, and rgdal packages. The average of sand fly abundance was
then estimated for each municipality through the obtained model (model details are reported in the
Supplementary Materials).
Table 1. Entomological data employed to implement the model with reference to the provinces where
sand fly collection took place (July–August 2014).
Entomological Data Bologna Province Ferrara Province Ravenna Province
Number of traps 32 21 9
Traps collecting sand flies 25 2 2
Collected sand flies 1688 2 30
Maximum number of sand flies per trap 1081 1 27
2.3.2. Data Analysis
A binomial logistic regression model was used to evaluate the correlation between the TOSV
seroprevalence at each municipality and sand fly abundance (SA). To reduce the high variability typical
of the vector population, the abundance was log10 transformed before binominal logistic regression
model analysis was employed. For each municipality, results from the prevalence observed in BD (p+)
were analyzed separately by means of binomial logistic regression with log10 SA as covariate.
Logistic (p+) = Ln [p+/(1 − p+)] = a + b (log10 SA) (1)
To avoid 0 prevalence results and to consider the uncertainty introduced by sampling on the true
prevalence estimation, the mean of a beta function was used. Using Bayes’ theorem where no prior
knowledge of the prevalence in the BD population is assumed, the fraction of positive donors could be
assumed to follow a Beta distribution [21]; if we assume a uniform (0.1) prior distribution for p+ (the
probability of being positive) and find K of M positive donors, the posterior distribution of positive
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donors was modeled as: p+ = Beta (K + 1; M − K + 1). Finally, only municipalities with at least 20 BDs
analyzed were considered in the logistic regression. Intercooled Stata 7.0 software (Stata Corporation,
College Station, TX, USA) was used for statistical data analysis. Significance was established at p < 0.05.
A map showing the TOSV-positive BDs and the sand fly abundance for each municipality was created
in the open source Geographic Information System (GIS) software QGIS 2.18 (www.qgis.org).
3. Results
3.1. TOSV Serological Studies
As shown in Table 2, 151 ELISA-reactive samples were found in Bologna and only two samples
in Ferrara.
Table 2. Detection of anti-TOSV IgG by ELISA in blood donors from the Bologna and Ferrara provinces
(Northeastern Italy), April–July 2014.
Detection of Anti-TOSV IgG by ELISA Bologna Province(Total BDs = 1008)
Ferrara Province
(Total BDs = 200)
Number of positive BD samples for anti-TOSV IgG 123 2
Number of border line BD samples for anti-TOSV IgG 28 0
Total ELISA-reactive samples 151 (15%) 2 (1%)
BD, blood donor.
The ELISA-reactive samples were then tested by IIF and MN (Table 3). None of the BD sera
collected from the Ferrara province tested positive by IIF or MN. On the contrary, among the 151 ELISA
reactive sera coming from Bologna province, 59 showed specific antibody by IIF and 61 by MN,
with neutralizing antibody titers ranging from 1/40 to 1/160. IIF revealed also five reactive samples for
anti-SFSV IgG, 23 for anti-SFNV IgG, and three for anti-SFCV IgG.
Table 3. Detection of anti-TOSV IgG by indirect immunofluorescence assay (IIF) and microneutralization
test (MN) in BDs that previously tested positive or borderline by ELISA-IgG. IIF: indirect
immunofluorescence assay; MN: microneutralization assay; TCID50: 50% Tissue Culture Infective Dose.
Test to Detect Anti-TOSV IgG Bologna Province (n = 151) Ferrara Province (n = 2)
IIF 59 0
MN 61 0
TOSV MN (100TCID50) titers
1/40 (n = 22)
1/80 (n = 27)
1/160 (n = 12)
Eighteen out of 151 ELISA-reactive samples exhibited discordant results when tested by IIF and
MN; 10 specimens tested positive by MN and negative by IIF, while 8 samples tested MN-negative and
IIF-positive (Table 4). A complete agreement between the two second-level tests was obtained in 51
positive samples and 82 negative samples. None of the 23 samples that tested positive for anti-SFSV
IgG, anti-SFNV IgG, or anti-SFCV IgG by IIF exhibited anti-SFSV neutralizing antibodies.
Table 4. Results obtained by indirect immunofluorescence assay (IIF) and microneutralization test
(MN) in sera from 151 BDs that tested positive or borderline by ELISA.
Second Level Tests MN+ MN− Total
IIF+ 51 8 59
IIF− 10 82 92
Total 61 90 151
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Serum samples were defined as positive for anti-TOSV IgG when reactive by ELISA and by at
least one second level test (IIF and/or MN, Figure 1). Sixty-nine BDs tested positive for anti-TOSV
antibodies in the Bologna province (51 MN-positive/IIF-positive, 10 MN-positive/IIF-negative, and eight
IIF-positive/MN-negative) and none in the Ferrara province, respectively. Thus, seroprevalence for
TOSV was 6.8% in the Bologna province and 0% in the Ferrara province. The highest number of
anti-TOSV positive samples was from BDs residing in the municipalities of Bologna, Casalecchio di
Reno, Zola Predosa, and Valsamoggia (Figure 2a and Supplementary Materials).
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Figure 2. (a) Distribution of blood donors included in the study (light blue circles) and anti-TOSV
IgG-positive individuals (red-colored circles) for each municipality in the surveyed area (circle areas are
proportional to the effective number of individuals, reference number in the legend). (b) Choropleth
map of the estimation of sand fly abundance obtained by the model for each municipality (from 0 to
3000 sand flies sampled). (c) Location of the surveyed area in Northeastern Italy.
3.2. Sand Fly Abundance Modelling
The implemented model produced an estimation of total sand fly number at 250 m × 250 m
resolution (see Supplementary Materials). The observed seroprevalence was strongly associated
with the estimated sand fly abundance (Figure 2b), as pointed out by the results of the binomial
logistic regression model (p < 0.001). According to this model, 75.5% of the variability observed in
the prevalence of TOSV-IgG positive BD per municipality was explained by the estimated abundance
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of sand flies in the site following the equation: Logistic (p+) = 0.29 × log10 (SA) − 2.651 (R2 = 0.755).
The equation indicates that the prevalence of TOSV antibody in BDs (logistic transformation) is
positively associated to the abundance of the vectors in the different municipalities.
4. Discussion
In this study, we observed that anti-TOSV positive BDs resided mainly in municipalities of the
Bologna province, while no active TOSV circulation was observed in the Ferrara province; these findings
match with estimated abundance of sand flies in these two provinces of Northeastern Italy. Between 2010
and 2013, 143 cases of neuroinvasive infection caused by TOSV were identified in the Emilia-Romagna
region, Northeastern Italy; the highest number of TOSV cases was recorded in the Bologna province
and the lowest number in the Ferrara province [17,18]. In line with the distribution of symptomatic
TOSV cases, our serosurvey identified a high circulation of TOSV in the Bologna province, with a
seroprevalence of 6.8%, while no TOSV circulation was observed in the Ferrara province.
The seroprevalence of TOSV was previously investigated in other Italian regions; studies on
the antibody prevalence rate of TOSV were performed by employing ELISA in Piedmont (Northern
Italy), Tuscany (Central Italy), and Sicily (Southern Italy), highlighting seroprevalence rates ranging
from 3% to 33% with a north to south gradient [8,22]. Other studies from Southern Europe indicate
seroprevalence rates for TOSV ranging from 12% to 38% by employing either ELISA or IIF [14,23–26].
Considering only the results obtained by ELISA, the abovementioned seroprevalence rates would
be comparable to the data obtained in this study; 13% of our BD samples were reactive by ELISA.
Nevertheless, we decided to define a serum sample as positive for anti-TOSV IgG when reactive by
ELISA and by at least one second level test in order to increase the specificity of our results. Thus,
the employment of a stringent condition for seropositivity in the current study can explain the lower
TOSV seroprevalence rate in Northeastern Italy as compared to other Italian and Southern European
regions, despite the high incidence of TOSV neuroinvasive cases in this area.
To our knowledge, few studies assessed TOSV seroprevalence in Europe by a combination
of tests [27,28]. In addition, only one study employed MN as a confirmatory test, showing a 5%
seroprevalence for TOSV in Turkey [27], which is in line with our results. In agreement with our
findings, a study performed in 2011 on 2625 BD plasma samples collected in Southeastern France
showed ELISA and MN rates of 7.3% and 2.1%, respectively [29].
In the current study, 18 out of 151 ELISA-reactive samples showed discordant results when tested
by IIF and MN. Ergunay and colleagues previously observed this phenomenon in TOSV infection [30],
and other studies involving arboviruses such as yellow fever virus also showed that the correlation
of ratio/titers for IIF to MN was low [31]. Phlebovirus neutralization is a complex phenomenon
involving several antigens on viral glycoproteins that may display considerable variation [29]. Further,
neutralizing epitopes can depend on protein tertiary structures that may be lost during IIF assay
development [30,32,33].
We observed that 23 samples tested positive for anti-SFSV IgG or anti-SFCV IgG by IIF, but all of
them were negative by SFSV MN, which is the optimal test in terms of specificity. As the serological
cross-reactivity among phleboviruses for certain serological tests is a known phenomenon [34],
this result could be explained with the presence of phleboviruses other than TOSV and SFSV circulating
in Northeastern Italy and infecting BDs. Consistent with this hypothesis, several phleboviruses with
unknown pathogenicity were detected in sand flies in the Bologna province [35,36].
The relation between an arthropod-borne pathogen and the abundance of its vector is difficult to
demonstrate without detailed entomological data. We overcame the unavailability of sand fly data at the
municipality level implementing a model to obtain a point estimate of the sand fly abundance. For this
estimation, we used some physical variable (land use and Digital Terrain Model), the Normalized
Difference Vegetation Index (June–September 2014), and weather data referred to 2001 to 2012 period,
which is long enough to represent the year of sampling. This approach allowed to show that abundance
of vectors parallels the rate of TOSV-positive donors in each municipality, identifying the abundance of
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sand flies as a factor that strongly influences TOSV seroprevalence in humans. The low abundance of
sand flies in the Ferrara province, as highlighted by vector analysis, is in line with the lack of anti-TOSV
IgG in BDs living in this area. A high abundance of sand flies was estimated in some municipalities of
the Bologna province, which coincides with areas that exhibit the highest TOSV seroprevalence.
The main limitation of this study is that the study group exclusively comprised healthy adults,
thus the results cannot be generalized to the overall population of the examined provinces.
5. Conclusions
The serosurvey carried out in 2014 showed different circulation of TOSV in different provinces of
Northeastern Italy, with a 6.8% TOSV seroprevalence in the Bologna province. Information provided
by this study may be useful for public health authorities, as our findings raise concerns about the
risk of TOSV transmission to virus-naive individuals by blood transfusion or organ transplantation;
TOSV has been isolated from human blood on several occasions [37], and this suggests that a potential
risk for virus transmission by iatrogenic means exists.
Supplementary Materials: The following are available online at http://www.mdpi.com/2076-2607/8/2/145/s1.
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